Panadol Osteo price hike statement ambiguous but not misleading: ACCC – The Sydney Morning Herald


The Sydney Morning Herald

Panadol Osteo price hike statement ambiguous but not misleading: ACCC
The Sydney Morning Herald
Statements linking a price increase of Panadol Osteo to its removal from the Pharmaceutical Benefits Scheme were "ambiguous" but not misleading, an investigation by the Australian Competition and Consumer Commission has found.
Panadol price hike not misleading: ACCCNEWS.com.au

ACCC gives GSK the all-clear following Sussan Ley's referralThe Australian

all 3 news articles »

Recent Entries

Leave a Reply

You must be logged in to post a comment.

css.php

© 2010-2019 Andrew and Karla's Place All original content copyright Andrew and Karla's Place. All rights reserved. No reproduction allowed without written permission.